In Vivo Efficacy of the New Ketolide Telithromycin (HMR 3647) in Murine Infection Models

We compared the oral antibacterial activities of telithromycin (HMR 3647), a new ketolide drug, in different infections induced in mice by Staphylococcus aureus, Streptococcus pneumoniae, streptococci, enterococci, and Haemophilus influenzae with those of various macrolides and pristinamycin. Unlike...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bonnefoy, Alain, Guitton, Michele, Delachaume, Carole, Le Priol, Pascal, Girard, Anne-Marie
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2001
Konular:
Experimental Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC90532/
https://ncbi.nlm.nih.gov/pubmed/11353612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.6.1688-1692.2001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller